Home » GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE

GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE

March 23, 2006

GlaxoSmithKline has begun distributing a medicine tagged with radio frequency identification (RFID) technology as part of a pilot project to help protect patient safety.
Finanzen.net

KEYWORDS FDAnews Device Daily Bulletin

Upcoming Events

10Jan
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
12Feb
Increase Compliance, Reduce Risk with Integrated Digital Solutions: Create a Connected System and Streamline...
17Mar
FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers
19Mar
SOPs and Policies for the 21st Century: Why Less is More
20Apr
17th Annual Medical Device Quality Congress

New!

17th Medical Device Quality Congress

Learn More Here

GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Increase Compliance, Reduce Risk with Integrated Digital Solutions: Create a Connected System and Streamline...

FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers

SOPs and Policies for the 21st Century: Why Less is More

17th Annual Medical Device Quality Congress

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

483sOnline.com Your Personal Pre-inspection Toolkit

International Devices and Diagnostics Monitor

CryoLife’s Thoracoabdominal Stent Graft Receives CE Mark

House Judiciary Committee Advances Patent Abuse Legislation

New!

17th Medical Device Quality Congress